Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 16682496 | HLA-B*57 | viremia | NA | NA | NA | positive | |
| thus, analysis of low level viremia reveals an unexpectedly high level of ctl escape mutations reflecting selective pressure acting at hla-b*57-restricted epitopes in es. | |||||||
| 16860834 | HLA (HLA) | viremia | NA | NA | NA | unclassified | |
| these results indicate impaired hiv-specific memory cd8 t cell differentiation, regardless of level of control of viremia, epitopes targeted or restricting hla alleles. | |||||||
| 17173051 | HLA (HLA) | viremia | NA | NA | NA | unclassified | |
| association of the specific cd8(+) t-cell response with low viremia was independent of hla type and unrelated to epitope sequence conservation. | |||||||
| 17251285 | HLA-B*13 | viremia | NA | NA | NA | unclassified | |
| to better understand relationships between cd8+ t-cell specificity and the immune control of human immunodeficiency virus type 1 (hiv-1), we analyzed the role of hla-b*13, an allele associated with low viremia, in a cohort of 578 c clade-infected individuals in durban, south africa. | |||||||
| 17251285 | HLA-B*13 | viremia | NA | NA | NA | unclassified | |
| these b*13-restricted epitopes contribute to a broad gag-specific cd8+ response that is associated with the control of viremia. | |||||||
| 17251285 | HLA-CLASS I (HLA-CLASS I) | viremia | NA | NA | NA | unclassified | |
| these data are consistent with data from studies of other hla-class i alleles associated with hiv control that have shown that the targeting of multiple gag epitopes is associated with relative suppression of viremia. | |||||||
| 19116253 | HLA-B*58 | viremia | NA | NA | NA | unclassified | |
| the typical escape mutation (t242n) within this epitope diminishes viral replication capacity in chronically infected persons; however, little is known about tw10 epitope sequences in residual replicating viruses in b57/b*5801 ec and the extent to which mutations within this epitope may influence steady-state viremia. | |||||||
| 19116253 | HLA-B*57 | viremia | NA | NA | NA | unclassified | |
| the typical escape mutation (t242n) within this epitope diminishes viral replication capacity in chronically infected persons; however, little is known about tw10 epitope sequences in residual replicating viruses in b57/b*5801 ec and the extent to which mutations within this epitope may influence steady-state viremia. | |||||||
| 19494300 | HLA-B*08 | viremia | Indian | NA | NA | unclassified | |
| in a similar fashion, 50% of mamu-b*08-positive indian rhesus macaques control sivmac239 replication and become elite controllers with chronic-phase viremia <1000 viral rna copies/ml. | |||||||
| 19605490 | HLA (HLA) | arginine | NA | glutamine | NA | positive | |
| NA | |||||||
Copyright 2024